Queen Charlotte's and Chelsea Hospital is one of the oldest maternity hospitals in Europe, founded in 1739 in London. Until October 2000, it occupied a site at 339–351 Goldhawk Road, Hammersmith, but is now located between East Acton and White City, adjacent to the Hammersmith Hospital.

During the past decade, Queen Charlotte and Hammersmith Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Charlotte and Hammersmith Hospital" #1 sponsor was "Imperial College London" with 7 trials, followed by "Imperial College Healthcare NHS Trust" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Guy's and St Thomas' NHS Foundation Trust" with 1 trials sponsored and "KU Leuven" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Charlotte and Hammersmith Hospital" #1 collaborator was "Chelsea and Westminster NHS Foundation Trust" with 1 trials as a collaborator, "King's College London" with 1 trials as a collaborator and "Royal Brompton & Harefield NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Queen Charlotte and Hammersmith Hospital" are "Endometrial Cancer" (5 trials), "Endometrial Neoplasms" (4 trials), "Endometrial Hyperplasia" (3 trials), "Anxiety" (2 trials) and "Hot Flashes" (2 trials). Many other conditions were trialed in "Queen Charlotte and Hammersmith Hospital" in a lesser frequency.

Most popular intervention types in "Queen Charlotte and Hammersmith Hospital" are "Diagnostic Test" (4 trials), "Drug" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Elinzanetant (BAY3427080)" (2 trials), "Placebo" (2 trials), "3D Ultrasound" (1 trials), "Breast feeding" (1 trials) and "Echocardiography and ultrasound of arteries" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Charlotte and Hammersmith Hospital" are 12 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Queen Charlotte and Hammersmith Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Queen Charlotte and Hammersmith Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Charlotte and Hammersmith Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".